Similar efficacy and safety of once‐weekly dulaglutide in patients with type 2 diabetes aged ≥65 and <65 years
Author:
Affiliation:
1. Indiana University Indianapolis IN USA
2. Providence Medical Group Terre Haute IN USA
3. Eli Lilly and Company Toronto ON Canada
4. Eli Lilly and Company Indianapolis IN USA
Funder
Eli Lilly and Company
Publisher
Wiley
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.12687
Reference36 articles.
1. Global Prevalence of Diabetes
2. Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach
3. Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes
4. Is Diabetes Associated With Cognitive Impairment and Cognitive Decline Among Older Women?
5. Diabetes and Incidence of Functional Disability in Older Women
Cited by 39 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Efficacy and safety of glucagon-like peptide-1 receptor agonists in the elderly <i>versus</i> non-elderly patients with type 2 diabetes mellitus: insights from a systematic review;Endocrine Journal;2024
2. Treatment effect heterogeneity following type 2 diabetes treatment with GLP1-receptor agonists and SGLT2-inhibitors: a systematic review;Communications Medicine;2023-10-05
3. A feasibility study of the combination of intranasal insulin with dulaglutide for cognition in older adults with metabolic syndrome at high dementia risk – Study rationale and design;Mechanisms of Ageing and Development;2023-07
4. Precision medicine in type 2 diabetes: A systematic review of treatment effect heterogeneity for GLP1-receptor agonists and SGLT2-inhibitors;2023-04-22
5. Durability of glucose-lowering effect of dulaglutide in patients with type 2 diabetes mellitus: A real-world data study;Frontiers in Endocrinology;2022-10-31
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3